Putin’s war machine funding is unscathed by latest sanctions | The Japan Times

2022-10-01 09:46:34 By : Mr. King Zeng

It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

The U.S. sanctioned hundreds of Russian officials, lawmakers, family members and businesses Friday in what Treasury Secretary Janet Yellen called a “sweeping action,” but in reality the measures will have little practical effect on President Vladimir Putin’s ability to sustain his country’s economy with oil and gas revenue.

That raises fundamental questions about the effectiveness of sanctions, despite how big it looks on paper for the Biden administration to go after Russia’s central banker, Elvira Nabiullina, and Alexander Novak, the deputy prime minister and a key figure in Russia’s energy sector. A raft of sanctions so far haven’t materially affected the war on the ground in Ukraine or dented Putin’s determination to pursue it despite repeated setbacks.

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you can help us get the story right.

With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.

Your subscription plan doesn't allow commenting. To learn more see our FAQ

How China targets the global fish supply

New infectious threats are coming. The U.S. probably won’t contain them.

In first, North Korea tests missiles for fourth time in a week

U.S. would know if Russia prepares nuclear strike, experts say

Eisai drug's trial success raises hope for Alzheimer's prevention

Sponsored contents planned and edited by JT Media Enterprise Division.

The Japan Times LTD. All rights reserved.